citric acid, anhydrous has been researched along with allopurinol in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (36.36) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Masuda, A; Matsunaga, J; Matsushita, K; Matsuzaki, S; Tanikawa, K | 1 |
| Burkitt, MJ; Gilbert, BC | 1 |
| Sandvall, K; Tiselius, HG | 1 |
| Bataille, P; Fievet, P; Finet, M; Fournier, A; Renaud, H; Rogez, JC | 1 |
| Harvey, JA; Pak, CY | 1 |
| Preminger, GM | 1 |
| Vile, GF; Winterbourn, CC | 1 |
| Churchill, DN | 1 |
| Conn, RL; Kanig, SP | 1 |
| Al-Khader, A; Cohen, SL; Edgar, L; Kasidas, GP; Krywawych, S; Rose, GA; Tomlinson, B | 1 |
| Pak, CY | 2 |
| Danielson, BG; Pak, CY; Robertson, WG; Smith, LH; Vahlensieck, W | 1 |
| Nicar, M; Northcutt, C; Pak, CY | 1 |
| Advani, SH; Basade, M; Dhar, AK; Kulkarni, SS; Kurkure, PA; Nair, CN; Pai, SK; Parikh, BS; Sastry, PS; Yadav, RP | 1 |
| Bell, PR; Chadwick, D; Davies, J; James, R; London, NJ; Robertson, GS; Swift, S; Thirdborough, S | 1 |
| Baumert, H; Bon, D; Caritez, JC; Carretier, M; Eugene, M; Goujon, JM; Hauet, T; Le Moyec, L; Mothes, D; Robert, R; Tallineau, C | 1 |
| Busza, AL; Fuller, BJ; So, PW | 1 |
| Carretier, M; Eugene, M; Goujon, JM; Hauet, T; Tallineau, C; Tillement, JP | 1 |
| Baumert, H; Carretier, M; Eugene, M; Gibelin, H; Goujon, JM; Hameury, F; Hauet, T | 1 |
| Pearle, MS | 1 |
| Tiselius, HG | 1 |
| Faraci, FM; Gunnett, CA; Heistad, DD | 1 |
| Fujioka, H; Honda, M; Komori, K; Momohara, C; Takada, T; Yamamoto, K | 1 |
| Ashizawa, N; Matsumoto, K; Nagata, O; Nakazawa, T; Shimo, T | 1 |
| Ahmad, N; Lodge, JP; Potts, DJ; Pratt, JR | 1 |
| Funahashi, M; Murayama, T; Yamada, T | 1 |
| Boll, M; Ermler, U; Friedrich, T; Johannes, J; Unciuleac, MC; Warkentin, E | 1 |
| Ito, H; Ito, Y; Kino, T; Matsuzawa, Y; Nishikawa, T; Omura, M; Saito, J; Yajima, Y; Yoshimura, K | 1 |
| Dallas, P; Denberg, TD; Forciea, MA; Qaseem, A; Starkey, M | 1 |
| Ding, Y; Hua, K; Liu, Y; Zhang, X; Zhang, Y | 1 |
4 review(s) available for citric acid, anhydrous and allopurinol
| Article | Year |
|---|---|
[Medical treatment of idiopathic calcium lithiasis (II)].
Topics: Allopurinol; Benzothiadiazines; Calcium; Cellulose; Citrates; Citric Acid; Diuretics; Humans; Magnesium; Pentosan Sulfuric Polyester; Phosphorus; Phytic Acid; Pyridoxine; Sodium Chloride Symporter Inhibitors; Succinimides; Urinary Calculi | 1985 |
The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.
Topics: Allopurinol; Benzothiadiazines; Calcium; Calcium Oxalate; Calcium, Dietary; Cellulose; Citrates; Citric Acid; Diet, Sodium-Restricted; Diuretics; Humans; Kidney Calculi; Phosphates; Sodium Chloride Symporter Inhibitors | 1982 |
Prevention of nephrolithiasis.
Topics: Allopurinol; Ascorbic Acid; Benzothiadiazines; Calcium, Dietary; Citric Acid; Diet; Dietary Proteins; Diuretics; Drinking; Humans; Kidney Calculi; Magnesium; Oxalic Acid; Phosphates; Recurrence; Risk Factors; Sodium Chloride Symporter Inhibitors; Sodium, Dietary | 2001 |
Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.
Topics: Allopurinol; Antimetabolites; Ascorbic Acid; Calcium Oxalate; Calcium, Dietary; Citric Acid; Dietary Fiber; Dietary Proteins; Drinking; Glycosaminoglycans; Humans; Magnesium; Patient Compliance; Phosphates; Recurrence; Thiazoles; Urinary Calculi | 2001 |
5 trial(s) available for citric acid, anhydrous and allopurinol
| Article | Year |
|---|---|
Treatment of bilateral urolithiasis.
Topics: Adult; Allopurinol; Citrates; Citric Acid; Combined Modality Therapy; Female; Humans; Lithotripsy; Male; Middle Aged; Recurrence; Retrospective Studies; Trichlormethiazide; Urinary Calculi | 1992 |
Medical management of nephrolithiasis.
Topics: Allopurinol; Ambulatory Care; Benzothiadiazines; Calcium; Calcium Oxalate; Calcium, Dietary; Cation Exchange Resins; Cellulose; Citrates; Citric Acid; Clinical Trials as Topic; Diuretics; Fluid Therapy; Humans; Kidney Calculi; Phosphates; Recurrence; Sodium Chloride Symporter Inhibitors; Uric Acid | 1982 |
Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy.
Topics: Adolescent; Allopurinol; Child; Child, Preschool; Citrates; Citric Acid; Female; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Leukocyte Count; Leukocytosis; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies | 1995 |
Human islet isolation--a prospective randomized comparison of pancreatic vascular perfusion with hyperosmolar citrate or University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Cell Survival; Citrates; Citric Acid; Cold Temperature; Collagenases; Glutathione; Humans; Insulin; Ischemia; Islets of Langerhans; Organ Preservation Solutions; Osmolar Concentration; Pancreas; Perfusion; Prospective Studies; Raffinose; Random Allocation; Tissue Donors | 1993 |
The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol.
Topics: Allopurinol; Citric Acid; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Prospective Studies; Uric Acid; Xanthine Oxidase | 2010 |
24 other study(ies) available for citric acid, anhydrous and allopurinol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Model studies of the iron-catalysed Haber-Weiss cycle and the ascorbate-driven Fenton reaction.
Topics: Ascorbic Acid; Citrates; Citric Acid; Edetic Acid; Electron Spin Resonance Spectroscopy; Ferric Compounds; Ferrous Compounds; Hydroxides; Hydroxyl Radical; Hydroxylation; Iron; Nitrilotriacetic Acid; Oxidation-Reduction; Pentetic Acid; Phytic Acid; Salicylates; Salicylic Acid; Succinates; Succinic Acid; Xanthine; Xanthine Oxidase; Xanthines | 1990 |
How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
Topics: Allopurinol; Bendroflumethiazide; Calcium Oxalate; Citrates; Citric Acid; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Magnesium Oxide; Male; Outpatient Clinics, Hospital; Phosphates; Recurrence; Urinary Calculi | 1990 |
Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
Topics: Allopurinol; Calcium Oxalate; Citrates; Citric Acid; Disease Susceptibility; Gout; Humans; Kidney Calculi; Male; Middle Aged; Prednisone; Recurrence; Sarcoidosis | 1988 |
Pharmacologic treatment of uric acid calculi.
Topics: Allopurinol; Citrates; Citric Acid; Dietary Proteins; Fluid Therapy; Humans; Methionine; Uric Acid; Urinary Calculi | 1987 |
High-affinity iron binding by xanthine oxidase.
Topics: Adenosine Triphosphate; Binding Sites; Catalysis; Chelating Agents; Chlorides; Citrates; Citric Acid; Ferredoxin-NADP Reductase; Ferric Compounds; Kinetics; Protein Binding; Xanthine Oxidase | 1986 |
Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal.
Topics: Allopurinol; Benzothiadiazines; Calcium; Cellulose; Citrates; Citric Acid; Diuretics; Humans; Magnesium; Recurrence; Sodium Chloride Symporter Inhibitors; Urinary Calculi | 1987 |
Kidney stones. Medical management and newer options for stone 'removal'.
Topics: Allopurinol; Benzothiadiazines; Calcium; Cellulose; Citrates; Citric Acid; Cystoscopy; Diuretics; Fluid Therapy; Fluoroscopy; Humans; Kidney Calculi; Lithotripsy; Medical History Taking; Minerals; Oxalates; Phosphates; Pyridoxine; Sodium Chloride Symporter Inhibitors; Ureteral Calculi; Uric Acid; Urine | 1985 |
Mechanism of allopurinol action in calcium oxalate stone formers.
Topics: Allopurinol; Calcium Oxalate; Citrates; Citric Acid; Creatinine; Diphosphates; Humans; Kidney Calculi; Lactates; Lactic Acid; Oxalates; Uric Acid | 1981 |
Rational therapy of nephrolithiasis, Part II.
Topics: Allopurinol; Benzothiadiazines; Cellulose; Citrates; Citric Acid; Diuretics; Humans; Kidney Calculi; Sodium Chloride Symporter Inhibitors; Tiopronin | 1984 |
Treatment of Idiopathic calcium stone disease.
Topics: Allopurinol; Calcium Oxalate; Calcium, Dietary; Cellulose; Citrates; Citric Acid; Combined Modality Therapy; Fluid Therapy; Humans; Hydrochlorothiazide; Kidney Calculi; Magnesium; Oxalates; Phosphates; Urinary Calculi | 1983 |
Proton NMR spectroscopy as a novel approach to the monitoring of citrate and trimethylamine-N-oxide excretion after kidney preservation.
Topics: Adenosine; Allopurinol; Animals; Citric Acid; Glutathione; Insulin; Kidney; Magnetic Resonance Spectroscopy; Methylamines; Organ Preservation; Organ Preservation Solutions; Radiography; Raffinose; Swine | 1997 |
Metabolic effects of citrate in liver during cold hypoxia studied by 1H NMR spectroscopy.
Topics: Adenosine; Allopurinol; Animals; Citric Acid; Cold Temperature; Cryopreservation; Glutathione; Hypertonic Solutions; Hypoxia; Insulin; Liver; Magnetic Resonance Spectroscopy; Male; Organ Preservation Solutions; Raffinose; Rats; Rats, Sprague-Dawley | 1998 |
Efficiency of trimetazidine in renal dysfunction secondary to cold ischemia-reperfusion injury: a proposed addition to University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Citric Acid; Cold Temperature; Glomerular Filtration Rate; Glutathione; Humans; Insulin; Kidney; Kidney Transplantation; Kidney Tubules; Lactic Acid; Lipid Peroxidation; Organ Preservation; Organ Preservation Solutions; Perfusion; Raffinose; Reperfusion Injury; Swine; Trimetazidine | 1998 |
Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury.
Topics: Acetic Acid; Acetylglucosaminidase; Acute Kidney Injury; Adenosine; Allopurinol; Animals; Biomarkers; Citric Acid; Cold Temperature; Creatinine; Dimethylamines; Glutathione; Glutathione Transferase; Hypertonic Solutions; Insulin; Isoenzymes; Kidney; Kidney Medulla; Kidney Transplantation; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Methylamines; Organ Preservation; Organ Preservation Solutions; Raffinose; Reperfusion Injury; Swine; Transplantation, Autologous | 2000 |
Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Allopurinol; Animals; Arteries; Blood Glucose; Citric Acid; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Female; Fluorescent Dyes; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Phenanthridines; Polyethylene Glycols; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents; Xanthine Oxidase | 2002 |
[Oral chemolysis of uric acid stones].
Topics: Administration, Oral; Allopurinol; Citric Acid; Combined Modality Therapy; Drug Therapy, Combination; Humans; Hyperuricemia; Lithotripsy; Retrospective Studies; Treatment Outcome; Uric Acid; Urinary Calculi | 2003 |
Simultaneous treatment with citrate prevents nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
Topics: Animals; Citric Acid; Crystallization; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Kidney Diseases; Macaca fascicularis; Male; Nitriles; Pyridines; Rats; Rats, Sprague-Dawley; Xanthine; Xanthine Dehydrogenase; Xanthine Oxidase | 2005 |
Comparative efficacy of renal preservation solutions to limit functional impairment after warm ischemic injury.
Topics: Adenosine; Allopurinol; Animals; Citric Acid; Glutathione; Hypertonic Solutions; In Vitro Techniques; Insulin; Ischemia; Kidney; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Osmolar Concentration; Raffinose; Rats; Rats, Wistar; Reperfusion Injury; Sugar Phosphates; Temperature | 2006 |
[Two cases of uric acid stones unsuccessfully dissociated by oral chemolysis].
Topics: Administration, Oral; Allopurinol; Calcium Oxalate; Calcium Phosphates; Citric Acid; Female; Humans; Kidney Calculi; Lithotripsy; Male; Middle Aged; Uric Acid | 2006 |
Inhibitors of the molybdenum cofactor containing 4-hydroxybenzoyl-CoA reductase.
Topics: Anions; Azides; Citric Acid; Coenzymes; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Enzyme Reactivators; Kinetics; Metalloproteins; Molybdenum Cofactors; Oxidation-Reduction; Oxidoreductases Acting on CH-CH Group Donors; Pteridines; Thauera; Xanthine Oxidase | 2008 |
Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.
Topics: Adult; Allopurinol; Calcium Chelating Agents; Citric Acid; Fluid Therapy; Gout Suppressants; Humans; Nephrolithiasis; Secondary Prevention; Sodium Chloride Symporter Inhibitors | 2014 |
Morphologic assessment of hypertonic citrate adenine, histidine-tryptophan-ketoglutarate, and university of Wisconsin solutions for hypothermic uterus preservation in rats.
Topics: Adenine; Adenosine; Allopurinol; Animals; Citric Acid; Female; Glucose; Glutathione; Histidine; Insulin; Mannitol; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Raffinose; Rats; Tryptophan; Universities; Uterus; Wisconsin | 2021 |